CLOs on the Move

Stimwave Technologies

www.stimwavefreedom.com

 
Stimwave Technologies Inc is a privately-held medical device company engaged in the development, manufacture, commercialization and marketing of wireless microsize injectable medical devices for neurology markets. Stimwave strives to improve people`s lives through utilizing wireless neurostimulation technology that enables low cost alternatives to complicated and expensive surgery, coupled with convenient and safe methods of use easily incorporated into everyday life.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Scribe Healthcare Technologies

Scribe Healthcare Technologies is a Lake Forest, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

schwartz john c dds a professional corp

schwartz john c dds a professional corp is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

mercer island vterinary clinic

mercer island vterinary clinic is a Mercer Island, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

www.biosig.com

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.

Phoenix Bio-Tech Corp

Phoenix Bio-Tech Corp is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.